Opendata, web and dolomites

MagElastic SIGNED

Magneto-elastic technologies for point-of-care diagnostics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "MagElastic" data sheet

The following table provides information about the project.

Coordinator
THE UNIVERSITY OF EXETER 

Organization address
address: THE QUEEN'S DRIVE NORTHCOTE HOUSE
city: EXETER
postcode: EX4 4QJ
website: www.ex.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 99˙581 €
 EC max contribution 99˙581 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-4-2016-2017
 Funding Scheme CSA
 Starting year 2018
 Duration (year-month-day) from 2018-10-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THE UNIVERSITY OF EXETER UK (EXETER) coordinator 36˙175.00
2    META GROUP SRL IT (ROMA) participant 31˙875.00
3    PLATFORM KINETICS LIMITED UK (York) participant 31˙531.00

Map

 Project objective

The aim of MagElastic is to turn into a “ready for market” technology an innovation based on magnetoelastic micromotors, which was recently developed by FET-OPEN consortium ABIOMATER. It was demonstrated that such micromotors can function as microfluidic pumps, valves and stirrers, to manipulate liquids at microscopic scale. These properties show high potential in point-of-care (POC) diagnostics, since they allow for minimal volume of sample extraction, instantaneous application, and no reliance on the medical expertise or laboratory tools. The main objective of MagElastic is to set up a start-up/spin-off company for commercialising a blood plasma separation component which will enable to produce a range of point-of-care devices for diagnosis of many known illnesses. With only a prick of blood such a component can help saving a significant amount of time and costs, which are currently being lost in the necessity of involving specialised equipment and staff support to extract blood plasma. Because of it’s time efficiency, in some cases (such as Sepsis described below), such devices will allow to save lives. MagElastic will bring the current technology from TRL5/6 to TRL7 by engaging with early adopters that will test the new device in operational environment. Moreover MagElastic will pave the way for the commercialisation of the new device by meeting with potential customers, clients and commercial partners and facilitating access to potential investors. During the project, the University of Exeter and Platform Kinetics, owners of the results of the undergoing FET-OPEN project, will be supported by META Group, an experienced partner in exploitation of research results and access to investors.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MAGELASTIC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MAGELASTIC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

EDRA (2019)

Hardware-Assisted Decoupled Access Execution on the Digital Market: The EDRA Framework

Read More  

FLIX (2020)

FLow chemistry for Isotopic eXchange

Read More  

ATEMPGRAD (2019)

Analysing Temperature Effects with a Mobile and Precise Gradient Device

Read More